Webinar: Commercialisation & regulatory strategies for women’s health technology

Date: July 24 2024 

Time: 2:00PM BST

Presented by: Robin Stephens, CEO & Co-Founder, Psephos Biomedica and Erica Kantor, Head of Women’s Health, Sagentia Innovation

Hosted by: Science and Engineering Health Technologies Alliance (SEHTA)

Register here for the webinar

Psephos and Sagentia Innovation will be discussing the challenges women’s health start-ups face when developing their commercialisation strategies, particularly when choosing a regulatory pathway.

Is it better to take a direct-to-consumer approach? Or should you pursue a regulated medical device pathway?

Join our webinar to learn how – and when – to define your regulatory strategy to ensure your next women’s health innovation is a success.

Robin Stephens and Erica Kantor will be discussing:

  • The emerging women’s health technology landscape
  • The challenges women’s health start-ups face when developing and commercialising new solutions
  • The pros and cons of the direct-to-consumer approach, vs seeking regulatory approval
  • The key considerations in developing a successful commercialisation strategy

Register for the webinar hosted by the Science and Engineering Health Technologies Alliance (SEHTA) here.

Get in touch

By submitting your details you agree to us holding the personal data you've supplied for the purpose of processing your enquiry. For information about how we handle your data, please read our privacy policy